Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-22-015663

Options or other derivatives

  • CEO and President acquired 722,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
KLEMP WALTER V CEO and President 2022-06-20 Grant or award · Stock option (right to buy) +360,000 1,035,862 D
KLEMP WALTER V CEO and President 2022-06-20 Grant or award · Restricted Stock Units +362,000 1,397,862 D
Loading xslF345X03/rdgdoc.xml…